Critical

Multisystem inflammatory syndrome in children (MIS-C)

Inflammatory · Paediatric
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Post-infectious hyperinflammatory syndrome (often weeks after SARS-CoV-2) with fever, shock, GI symptoms and cardiac dysfunction; overlaps with Kawasaki disease.

Red flags

  • Shock
  • Ventricular dysfunction / arrhythmia
  • Coronary artery dilatation
  • Rapid deterioration

Assessment

Differential diagnosis

  • Kawasaki disease
  • Toxic shock syndrome
  • Bacterial sepsis
  • Myocarditis
  • Appendicitis / acute abdomen

Investigations

  • FBC, CRP, ferritin, LDH
  • Troponin and natriuretic peptide, ECG, echocardiography
  • Coagulation and D-dimer
  • Blood cultures and SARS-CoV-2 serology
  • U&E, LFTs, lactate

Management

  • Assess for shock and treat with careful fluid resuscitation
  • Early inotropes if fluid-refractory (watch cardiac function)
  • Send inflammatory and cardiac markers
  • Echocardiography for coronary and ventricular function
  • Start immunomodulation with specialist input
  • Admit to paediatric critical care

Drugs & doses

IVIG
Corticosteroids
Aspirin (Kawasaki-like features)
Inotropes / vasopressors as needed

Disposition

Paediatric critical care.

Complications & pitfalls

  • Cardiogenic shock
  • Coronary artery aneurysm
  • Arrhythmia
  • Multiorgan failure

Exam pearls

  • Cardiac dysfunction can dominate; fluid boluses may worsen it.
  • Consider it in a child with fever, shock and prior COVID-19 exposure.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.